Rare Cancers | Tumor

CURE’s rare cancers page is a go-to resource for oncology news and updates in the world of rare cancers Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in rare cancers.

HPV Causes Multiple Cancers, Though Knowledge on the Connection Is Lagging

April 18th 2023, 9:00pm

Article

HPV vaccination rates and public knowledge about the connection between the virus and certain cancer types are below what they should be, research found.

Remaining Positive Amidst a Stage 4 Rare GI Cancer Diagnosis

April 14th 2023, 7:00pm

Article

After being given 2 years to live by her oncologist, a mother of two children is trying her best to protect her family — and herself — from thinking too negatively despite having rare gastrointestinal cancer.

FDA Approves Zynyz for Subset of Patients With Rare Skin Cancer

March 22nd 2023, 6:31pm

Article

This FDA approval of Zynyz was based on findings from a study which demonstrated that the therapy improves responses in patients with locally advanced Merkel cell carcinoma.

Enhertu Provides Meaningful, Durable Responses in HER2-Expressing Solid Tumors

March 14th 2023, 9:00pm

Article

The phase 2 DESTINY-PanTumor02 trial included patients with HER2-expressing solid tumors such as bladder, pancreatic and rare tumors.

'Ugly Blessings’ and Blooming From Cancer’s Lessons

March 8th 2023, 4:00pm

Article

After being diagnosed with a rare cancer, I met some amazing people and have a new appreciation for life.

Dealing With Life-Changing Cancer My Own Way

March 5th 2023, 6:00pm

Article

When I sit down with my paint brush, despite my cancer history, I don’t feel different anymore.

I Wish I Advocated More When Doctors Told Me I Didn’t Have Cancer

February 27th 2023, 8:00pm

Article

On multiple occasions, doctors told me not to worry, but I ended up being diagnosed with a rare cancer called leiomyosarcoma.

Novel Drug to Be Tested in Rare Form of Eye Cancer

January 24th 2023, 2:00pm

Article

A phase 2 study will investigate the efficacy of darovasertib for patients with uveal melanoma and whether the drug can potentially result in lower radiation doses or fewer eye removal surgeries.

Lytogbi Continues to Improve Cholangiocarcinoma Outcomes

January 20th 2023, 2:00pm

Article

Lytgobi was approved for pretreated cholangiocarcinoma in September, and updated study findings support the drug’s continued approval.

Welireg Made a von Hippel-Lindau Survivor Feel Like a 'Medical Miracle'

December 15th 2022, 4:00pm

Podcast

When Sean Korbitz was a 20-year-old college student, his life trajectory changed with a rare cancer diagnosis, resulting in the removal of 40 tumors; fifteen years later, a new drug made him feel like a “medical miracle.”